gastroenteritis glp 1 GLP-1 and Anesthesia: Considerations and Cautions for CRNAs GLP-1s, Gut Motility & IBS

Given the observed increased risk of colorectal cancer among patients receiving GLP-1 receptor agonists, clinicians should approach long-term prescribing of these agents with careful consideration, particularly in individuals with additional risk factors for colorectal cancer, such as a family history, obesity, inflammatory bowel disease, or long-standing type 2 diabetes

a) NAPQI b) Glucose c) Urea d) Lactate Answer: a) NAPQI NAC acts as a precursor of: a) Tyrosine b) Cysteine c) Glycine d) Alanine Answer: b) Cysteine In lungs, NAC acts by: a) Increasing mucus b) Breaking disulfide bonds c) Increasing inflammation d) Blocking histamine Answer: b) Breaking disulfide bonds NAC reduces mucus: a) Volume b) Viscosity c) Production d) Color Answer: b) Viscosity NAC can be given via: a) Oral only b) IV only c) Oral, IV, inhalation d) Intramuscular only Answer: c) Oral, IV, inhalation NAC has which property

Your clinician will help you weigh your own risks of side effects with the likely benefits of treatment to help you decide if taking a GLP-1 RA makes sense for you

This allows them to treat the body in a sustained manner, requiring less frequent dosage than other drugs